Generalized Pustular Psoriasis Flares: Treatment Patterns in the Real-World Setting

Main Article Content

Megan Noe
Lawrence Rasouliyan
Layla Lavasani
a:1:{s:5:"en_US";s:20:"Boehringer Ingelheim";}

Marianne Laouri
Jamie Rhoads

Keywords

GPP, Generalized Pustular Psoriasis, Treatment Patterns, Flare

References

1.Navarini AA, Burden AD, Capon F, et al. European consensus statement on phenotypes of pustular psoriasis. J Eur Acad Dermatol Venereol. 2017;31(11):1792-1799. doi:10.1111/jdv.14386.

2. Choon SE, Navarini AA, Pinter A. Clinical Course and Characteristics of Generalized Pustular Psoriasis. Am J Clin Dermatol. 2022 Jan;23(Suppl 1):21-29. doi: 10.1007/s40257-021-00654-z.

3. Togo K, Yonemoto N. Real world data and data science in medical research: present and future. Jpn J Stat Data Sci. 2022;5(2):769-781. doi: 10.1007/s42081-022-00156-0.

4. Rasouliyan L, Kumar V, Walton SE, et al. Identifying generalized pustular psoriasis flares using natural language processing of unstructured clinical notes and structured procedure. Presented at 39th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE 2023), Halifax, Nova Scotia, Canada; August 23–27, 2023.

Article Sidebar

PDF
Published
Jan 16, 2024
DOI https://doi.org/10.25251/skin.8.supp.302

Article Details

How to Cite
Noe, M., Rasouliyan, L., Lavasani, L., Laouri, M., & Rhoads, J. (2024). Generalized Pustular Psoriasis Flares: Treatment Patterns in the Real-World Setting. SKIN The Journal of Cutaneous Medicine, 8(1), s302. https://doi.org/10.25251/skin.8.supp.302
Issue
Vol. 8 No. 1 (2024): January 2024 Issue
Section
Poster Presentations from FC23 Dermatology Conference®: Psoriasis
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.